Loading...

PODCAST

Lab to Lives

Ivanna Rosendal

A simple question started this show: How do we medicine from the lab to making a difference in people"s lives as quickly as possible?The answers are complex. Actual solutions are hard to come by. We want to distill ideas until we see actual impact in the industry.Our three hosts all have backgrounds in life sciences and in improv comedy. Together, with their guests, they"re on a mission to have conversations that can have an impact. And have some fun along the way.

science life sciences

All Episodes

40:12

How Many Alexes Does It Take To Launch A Drug w/...

Lab to Lives ·

2026/09/30

Send us Fan Mail Europe looks like one market on a map, but try bringing a drug across borders and you quickly learn it behaves like many systems at once. We sit down with Daphne Smyth, a regulatory leader based in Ireland with 35+ years in pharmaceutical regulatory affairs, to unpack a mistake we keep seeing: companies build commercial teams first, then discover they have not built the regulatory pathway needed to launch at all. The result is not just delay, it is avoidable rework in clinica...

en-gb

47:06

Pharma Wants A Cupcake But Gets Ingredients w/ Dr....

Lab to Lives ·

2026/09/02

Send us Fan Mail Pharma doesn’t usually fail because the science is too hard. It stalls because humans are trying to do hard work inside a system that is overloaded, siloed and full of unwritten rules. We sit down with Isabelle, a physician with deep pharma experience who now works as a consultant, to unpack what really stops transformation and what actually helps teams move again. We talk about the five big value streams in a pharma company and why the friction between them becomes th...

en-gb

45:10

Enabling Clinical Trial Technology that Cuts Risk and...

Lab to Lives ·

2026/08/26

Send us Fan Mail Clinical trials are meant to generate evidence, not paperwork, but too many studies still depend on spreadsheets, duplicate data entry and unconnected systems. This episode we are joined by Karen Maduschke, a clinical trial technology leader with over 20 years of experience, from building one of the first interactive e-consent products to scaling trial tech through acquisition and entry into a global CRO environment. Together we explore one of most pressing challenges i...

en-gb

65:59

The Emperor’s Naked And The Trial’s Still On w/ Dr....

Lab to Lives ·

2026/07/08

Send us Fan Mail “Patients first” sounds simple until you follow the incentives. We’re joined by Dr Grant Coren, a genetics-trained PhD who moved from cancer research into decades of recruiting talent across the pharmaceutical industry and biotech. Together, we ask the uncomfortable question that sits under mission statements and glossy brand values: do pharma organisations truly value patients over profit, or do we build systems where profit is the only thing we reliably measure and reward?...

en-gb

51:40

What If The Real Blocker Is Coordination Not Data w/...

Lab to Lives ·

2026/06/10

Send us Fan Mail AI is everywhere in pharma right now, yet drug development still feels slow, fragmented, and full of avoidable rework. We sit down with Anastasia Christianson, former SVP and Global Head of AI Data and Analytics at Pfizer and now Managing Principal at EPAM Life Science Consulting, to get specific about what actually blocks progress in clinical trials and what AI can realistically change. We dig into the uncomfortable pattern behind many “successful” AI deployments: a model f...

en-gb

49:02

Electrifying the Factory: Agentic AI For Faster...

Lab to Lives ·

2026/05/13

Send us Fan Mail The clinical trial system is starting to look like a motorway at a standstill: more and more drugs are lining up, but the lanes ahead are already full. We sit down with Pamela Tenart to unpack why the industry may have reached the limit of human-only clinical development, and why “adding more people” is no longer a realistic plan when experienced CRAs, site co-ordinators and trial operators are already stretched thin. From there, we get practical about what agentic AI could ...

en-gb

69:21

Why Big Pharma Feels Like A Financial Institution &...

Lab to Lives ·

2026/04/15

Send us Fan Mail A medicine can be proven safe and effective, approved by regulators, and still fail the one test that matters: actually reaching patients in the real world. We sit down with Anish, a deep commercial thinker, to unpack what pharmaceutical commercialisation really is when you strip away the slogans and look at incentives, bottlenecks, and human behaviour. We start with our five value streams model of the pharmaceutical industry and use it to explore a provocative idea: m...

en-gb

48:51

How Biotech Ideas Become Real Patient Impact w/ new...

Lab to Lives ·

2026/03/30

Send us Fan Mail This is the first episode in the rebranded show! Drug and medical device breakthroughs do not reach patients because they’re clever in a lab. They reach patients when innovation, regulatory strategy, partnerships, clinical evidence and commercial reality line up at the same time, and that’s where things get messy. We’re launching Lab to Lives with a simple goal: talk honestly about what slows life sciences down and what actually helps. We start by introducing our new co-host...

en-gb

25:32

Dear Pharma, Your Patient Isn’t A KPI with Mark Duman

Lab to Lives ·

2026/03/03

Send a text What happens when we stop calling people “subjects” and start inviting them to help build the solutions they need? We sit down with pharmacist and patient engagement leader Mark Duman to unpack how language, literacy, and lived experience can transform clinical trials, medtech, and digital health from the ground up. Mark introduces his three Cs—co-creation, choice, and coaching—and shows how each one moves care from doing to people toward working with and learning from them. We d...

en-gb

39:12

Audit Trails, RBQM, And Agentic AI Explained

Lab to Lives ·

2026/02/11

Send a text Ever wondered why a clean CSR still leaves you unsure how a trial actually ran? We dive into the hidden layer that explains the “how”: audit trails across EDC, IRT, eConsent, and ePRO. With guests Ellis Hiroki of Study OS (now rebranded siteroAI) and Nechama Katan of Wicked Problem Wizard, we unpack how E6(R3) shifts sponsors from “we can export logs” to “we continuously analyse them,” and why process measures—not just outcomes—are essential to real RBQM. We break down the ...

en-gb

20:28

Why Bringing The Trial To The Patient Beats Dragging...

Lab to Lives ·

2026/01/28

Send us a text Want clinical research that respects real life? We sit down with Caroline Potts, GM of Site and Patient Services at MRN, to rethink how patients are recruited and supported when the standard trial model collides with work, school, caregiving, and distance. We start at the site level, exploring why trial sites remain the beating heart of studies, then unpack how participants actually arrive: investigator databases, advocacy networks, disease-specific portals, and focused social ...

en-gb

31:33

Inside Sionna’s Bid To Normalize CFTR Function

Lab to Lives ·

2025/12/17

Send us a text Two leaders from Sionna Therapeutics walk through a 15‑year journey from Genzyme science to a public company advancing NBD1‑targeted therapies in cystic fibrosis. We examine why most patients still fall short of normal CFTR, how a predictive assay de‑risks choices, and what it takes to finance, hire, and execute with patients as the North Star. Visit: sionnatx.com Transformation in Trials is a podcast investigating how we can change life sciences to get treatment to patient...

en-gb

24:03

AI Won’t Replace Writers, But Writers Who Use AI Will...

Lab to Lives ·

2025/12/03

Send us a text What if the documents behind a clinical trial were written with the patient’s voice in mind and delivered at the speed modern science deserves? We sit down with writer, consultant, and patient-advocate Bilal Bham to unpack how protocols, clinical trial applications, and clinical study reports actually get made, why structure beats chaos, and where AI genuinely shortens timelines without cutting corners. From first protocol outlines to final submissions, Bilal shares a process t...

en-gb

31:04

From Grief To Global Advocacy For Clinical Research...

Lab to Lives ·

2025/11/19

Send us a text A routine dental visit, a few days of diarrhea, and then the unthinkable: septic shock and a life lost within 24 hours. Our guest, Christian John Lillis, shares how losing his mother Peggy to a community-acquired C. diff infection exposed a silent public health crisis and led him to co-found the Peggy Lillis Foundation (https://cdiff.org/). From that moment, advocacy turned concrete: raising awareness, training volunteers to speak with lawmakers and media, and pushing for polic...

en-gb

31:41

Decoding Real-World Evidence: Beyond Clinical Trials...

Lab to Lives ·

2025/09/10

Send us a text What if millions of electronic health records could transform how we understand medicine? In this thought-provoking conversation with Dr. Manfred Stapff, physician and real-world evidence pioneer, we uncover how anonymized patient data is revolutionizing healthcare research. Dr. Stapff reveals how the 21st Century Cures Act dramatically accelerated electronic medical record adoption in the US, creating unprecedented opportunities for researchers. Today, with 90-95% of American...

en-gb

18:32

Democratizing Drug Development Through AI-Native...

Lab to Lives ·

2025/08/27

Send us a text Cloud computing is transforming biotech by offering purpose-built infrastructure that supports AI-driven drug discovery and development while meeting strict regulatory requirements. Dr. Ilya Burkov explains how Nebius provides full-stack solutions that democratize access to powerful technology, enabling researchers to achieve breakthroughs that previously required generations. • Cloud computing market was built for general purpose workloads but biotech needs specialized infras...

en-gb

27:44

Incorruptible Evidence: Blockchain's Promise for...

Lab to Lives ·

2025/08/13

Send us a text Dominik Lysek, CEO of PharmaTrail, explains how blockchain technology can solve trust issues in clinical trials by providing an incorruptible audit trail that verifies data integrity. This solution could significantly accelerate the time required for regulatory approvals, partnerships, and acquisitions, ultimately getting treatments to patients faster. • Blockchain provides a complete, unchangeable audit trail where data can only be added, never deleted • Most clinical data (9...

en-gb

38:48

How diseases work with Dr. Shervin Molayem

Lab to Lives ·

2025/07/16

Send us a text Dr. Shervin Molayem shares his journey of innovation in dentistry, starting with his discovery of a connection between periodontal disease and COVID-19 severity that became the world's most-read dental article of 2020. He discusses groundbreaking technologies including AI-powered diagnostic tools and a revolutionary non-surgical treatment that regenerates bone tissue around teeth. • Discovered connection between gum disease and COVID-19 severity through interleukin-6 levels • ...

en-gb

36:59

How early diagnostics of lung cancer can lead to...

Lab to Lives ·

2025/07/02

Send us a text Chris Wood discusses how early diagnostics of lung cancer through artificial intelligence and medical imaging can lead to better survival rates through early intervention. • Lung cancer takes more lives than breast, prostate and colon cancer combined, with approximately 70% of cases caught at late stages • The National Lung Screening Trial showed that screening high-risk populations reduced mortality by 20% • I-ELCAP research demonstrated an 80% twenty-year survival rate...

en-gb

53:36

From Hopeless to High-Performing: Transforming Pharma...

Lab to Lives ·

2025/06/18

Send us a text Building high-performing teams in life sciences requires understanding how neurodiversity can be an advantage and designing work systems that enable different brain types to collaborate effectively. • A high-performing team continues to function when everything around it has fallen apart • Star players can become crutches that mask underlying team issues • Life sciences faces unique challenges: financial pressures, outdated technology, layoffs, and pervasive lack of trust • Te...

en-gb

98 results

Similar Podcasts

Beyond the Divide

Koala Moon

The SCP Experience

Dr. NoSleep Studios

John Michael Godier"s Event Horizon

John Michael Godier

La Science CQFD

France Culture

A Moment of Science

Indiana Public Media